MENU
+Compare
VYGR
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$4.22
Change
-$0.04 (-0.94%)
Capitalization
230.79M

VYGR Voyager Therapeutics Forecast, Technical & Fundamental Analysis

a developer of gene therapies for fatal and debilitating diseases of the central nervous system

Industry Biotechnology
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for VYGR with price predictions
Feb 21, 2025

VYGR sees MACD Histogram crosses below signal line

VYGR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on February 11, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 38 instances where the indicator turned negative. In of the 38 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VYGR as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VYGR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VYGR entered a downward trend on February 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VYGR advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

VYGR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.699) is normal, around the industry mean (12.496). P/E Ratio (6.402) is within average values for comparable stocks, (84.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). VYGR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (1.439) is also within normal values, averaging (251.218).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VYGR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VYGR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VYGR is expected to report earnings to rise 135.00% to -37 cents per share on March 11

Voyager Therapeutics VYGR Stock Earnings Reports
Q4'24
Est.
$-0.38
Q3'24
Beat
by $0.29
Q2'24
Beat
by $0.23
Q1'24
Beat
by $0.24
Q4'23
Beat
by $1.54
The last earnings report on November 12 showed earnings per share of -15 cents, beating the estimate of -44 cents. With 282.62K shares outstanding, the current market capitalization sits at 230.79M.
A.I. Advisor
published General Information

General Information

a developer of gene therapies for fatal and debilitating diseases of the central nervous system

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
75 Hayden Avenue
Phone
+1 857 259-5340
Employees
162
Web
https://www.voyagertherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMYAX44.34N/A
N/A
Putnam Core Equity Fund A
MPLIX13.76N/A
N/A
Praxis International Index I
DFMIX35.62N/A
N/A
Davidson Multi-Cap Equity I
PSPIX25.88N/A
N/A
Principal SmallCap S&P 600 Index R6
FSZZX9.32N/A
N/A
Fidelity Advisor Sustainable EM Eq Z

VYGR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-0.94%
RGNX - VYGR
46%
Loosely correlated
-1.22%
RCKT - VYGR
43%
Loosely correlated
-3.68%
XENE - VYGR
41%
Loosely correlated
+0.89%
ACLX - VYGR
40%
Loosely correlated
-2.83%
DNLI - VYGR
39%
Loosely correlated
-3.98%
More